menu
    • menu

    Company profile for IVERIC bio

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    IVERIC bio is a biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with significant unmet medical needs. We are particularly interested in adeno-associated virus (AAV) gene therapy delivery vehicles. AAV vectors have a well-documented safety record for gene delivery in the eye, targeting specific cells of interest, thereby minimizing off-target side effects. Orpha...
    IVERIC bio is a biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with significant unmet medical needs. We are particularly interested in adeno-associated virus (AAV) gene therapy delivery vehicles. AAV vectors have a well-documented safety record for gene delivery in the eye, targeting specific cells of interest, thereby minimizing off-target side effects. Orphan inherited retinal diseases are generally caused by many different mutations within a single gene. Our strategy is to develop mutation independent treatment options to potentially treat the entire class of a disease.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    IVERIC bioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    One Penn Plaza Suite 3520 New York, NY 10119
    Telephone
    Telephone
    (212) 845-8200
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://ivericbio.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/ivericbio
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Astellas cruises into first DTC campaign for GA med Izervay
    Astellas cruises into first DTC campaign for GA med Izervay

    30 Sep 2024

    // Andrea Park FIERCE PHARMA

    https://www.fiercepharma.com/marketing/astellas-cruises-1st-dtc-campaign-geographic-atrophy-treatment-izervay

    Andrea Park FIERCE PHARMA
    30 Sep 2024
    Share Share
    Eric Stonestreet, Partners with Iveric Bio to Raise Awareness of GA
    Eric Stonestreet, Partners with Iveric Bio to Raise Awareness of GA

    20 Sep 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/two-time-emmy-award-winning-actor-eric-stonestreet-partners-with-iveric-bio-to-raise-awareness-of-geographic-atrophy-ga-301932343.html

    PR NEWSWIRE
    20 Sep 2023
    Share Share
    Iveric Announces Positive 24-Month Topline Results from Phase 3 Study of IZERVAY
    Iveric Announces Positive 24-Month Topline Results from Phase 3 Study of IZERVAY

    18 Sep 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/iveric-bio-announces-positive-24-month-topline-results-from-phase-3-study-of-izervay-avacincaptad-pegol-intravitreal-solution-for-geographic-atrophy-301931191.html

    PR NEWSWIRE
    18 Sep 2023
    Share Share
    EMA Accepts Iveric's Marketing Authorization Application for Avacincaptad Pegol
    EMA Accepts Iveric's Marketing Authorization Application for Avacincaptad Pegol

    17 Aug 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/european-medicines-agency-accepts-iveric-bios-marketing-authorization-application-for-avacincaptad-pegol-for-geographic-atrophy-301904137.html

    PR NEWSWIRE
    17 Aug 2023
    Share Share
    Iveric Receives FDA Approval for IZERVAY, a New Treatment for Geographic Atrophy
    Iveric Receives FDA Approval for IZERVAY, a New Treatment for Geographic Atrophy

    05 Aug 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/iveric-bio-receives-us-fda-approval-for-izervay-avacincaptad-pegol-intravitreal-solution-a-new-treatment-for-geographic-atrophy-301894042.html

    PR NEWSWIRE
    05 Aug 2023
    Share Share
    Astellas Completes Acquisition of Iveric Bio
    Astellas Completes Acquisition of Iveric Bio

    11 Jul 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/astellas-completes-acquisition-of-iveric-bio-301874923.html

    PR NEWSWIRE
    11 Jul 2023
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search